Funding for this research was provided by:
Eli Lilly Japan
Article History
Accepted: 15 March 2023
First Online: 27 April 2023
Declarations
:
: This work was supported by Eli Lilly Japan K.K., Kobe, Japan.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: Toshiki Masuishi has received personal fees from Takeda, Chugai, Merck Bio Pharma, Taiho, Bayer, Eli Lilly Japan K.K., Yakult Honsha, Ono, Bristol Myers Squibb, Daiichi Sankyo, and Sanofi, and grants from MSD, Daiichi Sankyo, Ono, and Novartis. Soshi Nagaoka is an employee of Eli Lilly Japan K.K. and a shareholder of Eli Lilly and Company. Long Jin is an employee of Eli Lilly Japan K.K. Kenichi Yoshizawa is an employee of Eli Lilly Japan K.K. and a shareholder of Eli Lilly and Company, Bristol-Myers Squibb Company, and Merck & Co., Inc.
: Due to the observational nature of this research, consent to share data publicly could not be obtained from the participants of this study, therefore supporting data are not available.
: The study was conducted in accordance with the standards of Good Post-marketing Study Practice for drugs (Ordinance No. 171, issued 20 December 2004, the Japanese Ministry of Health, Labour and Welfare). The study protocol adhered to applicable local and country-specific laws and regulations pertaining to protection of patient privacy and safety, and was reviewed by the Pharmaceuticals and Medical Devices Agency. In accordance with these laws and regulations, this study did not obtain written informed consent from enrolled patients and ethics approval was waived.
: Soshi Nagaoka was involved in the provision of study materials, data collection, and statistical analysis. Toshiki Masuishi and Long Jin were involved in study conception and the provision of study materials. Kenichi Yoshizawa was involved in study conception and design, administrative support, provision of study materials, and data collection. All authors were involved in data analysis and interpretation, drafting of the manuscript, and approval of the final version for publication.
: In accordance with the standards, informed consent from individual patients was not required.
: Not applicable.
: Not applicable.